MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIRDSALL, N. J. M.
Right arrow Articles by HULME, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BIRDSALL, N. J. M.
Right arrow Articles by HULME, E. C.

Molecular Pharmacology, Vol 14, 723-736, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

The Binding of Agonists to Brain Muscarinic Receptors

N. J. M. BIRDSALL 1, A. S. V. BURGEN 1, and E. C. HULME 1

1 Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London NW7 1AA, UK

The interaction of agonists with muscarinic receptors has been investigated by measuring the binding of [3H]muscarinic agonists to membrane preparations from the rat cortex and by means of [3H]agonist/agonist and [3H]antagonist/agonist competition experiments. The binding data can be explained by the presence of two major populations of agonist binding sites which do not interconvert during the binding experiments and have the same affinity constants for antagonists. The ratio of the affinity constants of an agonist for the two sites can vary from 1 to about 275. There is quantitative agreement between the agonist affinity constants for the two sites and parameters derived from the action of muscarinic agonists on smooth muscle, A third (minor) population of "super-high" affinity agonist binding sites has been detected.

Note:
ACKNOWLEDGMENTS The authors wish to thank P. Mehta and R. Edees for skilled technical assistance and Drs. C. R. Hiley and J. M. Young for their permission to include some of their unpublished results in Table 7.

Submitted on December 9, 1977
Accepted on April 24, 1978




This article has been cited by other articles:


Home page
J. Physiol.Home page
V. Snitsarev, C. A. Whiteis, M. W. Chapleau, and F. M. Abboud
Mechano- and chemosensitivity of rat nodose neurones - selective excitatory effects of prostacyclin
J. Physiol., July 1, 2007; 582(1): 177 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Slutsky, G. Rashkovan, H. Parnas, and I. Parnas
Ca2+-Independent Feedback Inhibition of Acetylcholine Release in Frog Neuromuscular Junction
J. Neurosci., May 1, 2002; 22(9): 3426 - 3433.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Waelbroeck
Activation of Guanosine 5'-[{gamma}-35S]thio-triphosphate Binding through M1 Muscarinic Receptors in Transfected Chinese Hamster Ovary Cell Membranes: 1. Mathematical Analysis of Catalytic G Protein Activation
Mol. Pharmacol., April 1, 2001; 59(4): 875 - 885.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Ilouz, L. Branski, J. Parnis, H. Parnas, and M. Linial
Depolarization Affects the Binding Properties of Muscarinic Acetylcholine Receptors and Their Interaction with Proteins of the Exocytic Apparatus
J. Biol. Chem., October 8, 1999; 274(41): 29519 - 29528.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
V. T. Nguyen, T. X. Lee, A. Ndoye, L. D. Shultz, M. R. Pittelkow, M. V. Dahl, P. J. Lynch, and S. A. Grando
The Pathophysiological Significance of Nondesmoglein Targets of Pemphigus Autoimmunity: Development of Antibodies Against Keratinocyte Cholinergic Receptors in Patients With Pemphigus Vulgaris and Pemphigus Foliaceus
Arch Dermatol, August 1, 1998; 134(8): 971 - 980.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. K. Vogel, D. M. Sheehan, and M. I. Schimerlik
Site-Directed Mutagenesis on the m2 Muscarinic Acetylcholine Receptor: The Significance of Tyr403 in the Binding of Agonists and Functional Coupling
Mol. Pharmacol., December 1, 1997; 52(6): 1087 - 1094.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
Z.-L. Lu, C. A. Curtis, P. G. Jones, J. Pavia, and E. C. Hulme
The Role of the Aspartate-Arginine-Tyrosine Triad in the m1 Muscarinic Receptor: Mutations of Aspartate 122 and Tyrosine 124 Decrease Receptor Expression but Do Not Abolish Signaling
Mol. Pharmacol., February 1, 1997; 51(2): 234 - 241.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics